HomeCategoryTherapeutics - Verséa

https://i0.wp.com/www.versea.com/wp-content/uploads/2023/01/IMG_3986-scaled.jpg?resize=1280%2C640&ssl=1

Members of our Verséa Biologics team (Sunil Panchal, MD, Chief Scientific Officer, Verséa Biologics; David Kloth, M.D., Medical Director, Verséa Biologics; and Bill Bigham, VP of Sales, Verséa Biologics) attended this year’s North American Neuromodulation Society 26th Annual Meeting. At the event they had a chance to present our innovative portfolio of Biologics products which...

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/03/vision-concept_800-e1648064890754.jpg?resize=800%2C464&ssl=1

A recently published peer-reviewed scientific article “Cannabinol Modulates Neuroprotection and Intraocular Pressure: A Potential Multi-Target Therapeutic Intervention for Glaucoma” has provided insight into unique therapeutic potential of Cannabinol (CBN) for glaucoma treatment   The article, published in a leading international journal Biochimica et Biophysical Acta (BBA – Molecular Basis of Disease) (LINK to the article)...